Monkeypox

As 2024 draws to a close, it leaves behind a series of impactful and memorable news stories that defined the year. When looking for information on top news stories, many people around the world turned to Google, the search engine owned by Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL), where they...

U.S. stocks showed signs of resilience as traders eagerly awaited Federal Reserve Chair Jerome Powell’s address at Jackson Hole on Friday. The minutes from the July FOMC meeting revealed that policymakers were considering a potential interest rate cut in September due to progress in curbing...

So-called “bull traps” often frustrate traders, as they did on Wednesday, snaring shares of SIGA Technologies Inc (NASDAQ:SIGA) — and there may be another one today. That's why it’s our ‘Stock of the Day'. SIGA shares have been very active because of a surge in Mpox (The World...

The World Health Organization (WHO) has declared mpox, a viral infection, a global public health emergency. This is the second such declaration in two years due to a new outbreak spreading across Africa. What Happened: The WHO made the declaration following an outbreak of the viral infection in the...

Blue Water Biotech Inc (NASDAQ: BWV) has released preliminary preclinical data that supports the potential use of its norovirus shell and protrusion (S&P) virus-like particle (VLP) platform for the development of a novel monkeypox vaccine candidate. In 2022, the Centers for Disease...

FDA has granted Emergency Use Authorization for Roche Holdings AG's (OTC: RHHBY) cobas MPXV for use on the cobas 6800/8800 Systems.  The test is a real-time PCR test for the qualitative detection of DNA from the monkeypox virus (MPXV) in lesion swabs collected from...

Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases between 2013 and 2017, scientists have found that monkeypox transmission in a remote part of the...

SIGA Technologies Inc (NASDAQ: SIGA) provided an update on the status of multiple clinical trials now underway to assess the safety and efficacy of TPOXX to treat monkeypox. In recent weeks, the company initiated trials in the U.S., the U.K., and Congo to further assess the safety...

SIGA Technologies Inc (NASDAQ: SIGA) announced that the U.S. Department of Defense (DoD) awarded a new contract to the company to procure up to $10.7 million of oral TPOXX. About $5.1 million of oral TPOXX is targeted for delivery in 2022, and the remainder is subject to an option at the...

SIGA Technologies Inc (NASDAQ: SIGA) received approximately $16 million in international procurement orders for oral TPOXX (tecovirimat) in August and early September. The orders include an approximate $10 million order by the European Commission and approximately $6 million of...

Virax Biolabs Group Ltd (NASDAQ: VRAX) has announced the distribution of a Monkeypox Antigen Rapid Test Kit launched in the European markets accepting the CE mark. The specialized diagnostic kits can be found by contacting the company’s sales representatives. Founded in 2013, in July...

The White House is seeking $44.5 billion in emergency funding from Congress for Covid-19 and monkeypox and back Ukraine, the Wall Street Journal reported citing administration officials. The White House is asking about $22.4 billion for Covid-19 vaccines, trials, and testing; $3.9...

According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be waning in Europe and the U.S. Public-health experts said they remain cautious about whether the outbreak has peaked as efforts continue to stretch limited...

In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018.  By 2001, SIGA shares were faltering, and...